Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Movement Disorders

ng-nitroarginine methyl ester has been researched along with Movement Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czarnecka, A; Konieczny, J; Lenda, T; Lorenc-Koci, E1
Dietrich, WD; Kuluz, JW; Prado, RJ; Schleien, CL; Watson, BD1

Other Studies

2 other study(ies) available for ng-nitroarginine methyl ester and Movement Disorders

ArticleYear
The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats.
    Brain research, 2015, Nov-02, Volume: 1625

    Topics: Adrenergic Agents; Animals; Apomorphine; Biogenic Monoamines; Brain; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Indazoles; Levodopa; Locomotion; Male; Movement Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Oxidopamine; Rats; Rats, Wistar; Time Factors

2015
The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats.
    Stroke, 1993, Volume: 24, Issue:12

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Body Weight; Cerebral Infarction; Ischemic Attack, Transient; Male; Movement Disorders; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar

1993